(Circulation. 2000;101:516.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Division of Nuclear Medicine (O.M., P.C., D.M.W., M.S.), University of Michigan, Ann Arbor, Mich; and Department of Nuclear Medicine (G.M., N.T.B.N., S.N., S.Z., M.S.), Technische Universität München, Munich, Germany.
Correspondence to Markus Schwaiger, MD, Nuklearmedizinische Klinik, Klinikum Rechts der Isar, Ismaningerstr 22, Munich, Germany 81675.
BackgroundThe goal of the present study was to directly compare the new radiopharmaceutical agent [11C]epinephrine (EPI) with [11C]hydroxyephedrine (HED) through the use of PET.
Methods and ResultsSeven healthy volunteers and 10 patients were
investigated after heart transplantation. PET images of both tracers
were of excellent quality in the volunteers. Values for radiolabeled
metabolites (measured in percent of blood activity) at 5, 20, and 60
minutes after injection were
35%,
82%, and
86% for EPI and
13%,
47%, and
78% for HED, respectively. At 35 minutes,
metabolite-corrected mean myocardial retention fraction of EPI
(0.235±0.022 min-1) was significantly greater
(P<0.01) than that of HED (0.142±0.012
min-1). Corrected tracer retention fractions of both EPI
and HED were significantly reduced in transplant recipients
(0.055±0.004 min-1, P<0.0001; and
0.050±0.006 min-1, P<0.0001,
respectively) compared with volunteers. Normalization of retention
fractions of patients with transplantation within 1 year to volunteers
resulted in a value (ratio expressed in percent) of 20.6±1.8%
for EPI, significantly (P<0.03) smaller than
27.8±0.8% for HED. In patients with transplantation later than 1
year, the values were 26.0±2.9% for EPI compared with 44.2±5.6% for
HED (P<0.014).
ConclusionsBoth tracers showed high selectivity for neuronal uptake in the heart, with a significant reduction in tracer retention in transplant recipients compared with volunteers. Compared with HED, EPI showed greater retention in volunteers and a lower retention ratio in transplant recipients, suggesting that EPI may be the superior tracer with higher sensitivity to neuronal abnormalities. Because EPI reflects neuronal uptake, metabolism, and storage, it may be more suitable for the study of neuronal integrity than HED, which primarily traces uptake-1 capacity.
Key Words: tomography, emission-computed heart transplantation epinephrine hydroxyephedrine
This article has been cited by other articles:
![]() |
E. Fricke, S. Eckert, A. Dongas, H. Fricke, R. Preuss, O. Lindner, D. Horstkotte, and W. Burchert Myocardial Sympathetic Innervation in Patients with Symptomatic Coronary Artery Disease: Follow-up After 1 Year with Neurostimulation J. Nucl. Med., September 1, 2008; 49(9): 1458 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Tipre, J. J. Fox, D. P. Holt, G. Green, J. Yu, M. Pomper, R. F. Dannals, and F. M. Bengel In Vivo PET Imaging of Cardiac Presynaptic Sympathoneuronal Mechanisms in the Rat J. Nucl. Med., July 1, 2008; 49(7): 1189 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sasano, M. R. Abraham, K.-C. Chang, H. Ashikaga, K. J. Mills, D. P. Holt, J. Hilton, S. G. Nekolla, J. Dong, A. C. Lardo, et al. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2266 - 2275. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Moroz, I. Serganova, P. Zanzonico, L. Ageyeva, T. Beresten, E. Dyomina, E. Burnazi, R. D. Finn, M. Doubrovin, and R. G. Blasberg Imaging hNET Reporter Gene Expression with 124I-MIBG J. Nucl. Med., May 1, 2007; 48(5): 827 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Bengel, P. Ueberfuhr, D. Schafer, S. G. Nekolla, B. Reichart, and M. Schwaiger Effect of Diabetes Mellitus on Sympathetic Neuronal Regeneration Studied in the Model of Transplant Reinnervation J. Nucl. Med., September 1, 2006; 47(9): 1413 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Buursma, A. M.J. Beerens, E. F.J. de Vries, A. van Waarde, M. G. Rots, G. A.P. Hospers, W. Vaalburg, and H. J. Haisma The Human Norepinephrine Transporter in Combination with 11C-m-Hydroxyephedrine as a Reporter Gene/Reporter Probe for PET of Gene Therapy J. Nucl. Med., December 1, 2005; 46(12): 2068 - 2075. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Bengel, P. Ueberfuhr, J. Karja, K. Schreiber, S. G. Nekolla, B. Reichart, and M. Schwaiger Sympathetic reinnervation, exercise performance and effects of {beta}-adrenergic blockade in cardiac transplant recipients Eur. Heart J., October 1, 2004; 25(19): 1726 - 1733. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology Eur. Heart J., May 2, 2004; 25(10): 815 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Carrio Cardiac Neurotransmission Imaging J. Nucl. Med., July 1, 2001; 42(7): 1062 - 1076. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |